Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Clinical effectiveness of early posaconazole suspension pre-emptive therapy in lung transplant recipients: The Alfred's experience

Jeong W, Snell GI, Levvey BJ, Westall GP, Morrissey CO, Ivulich S, Neoh CF, Slavin MA, Kong DCM

(2017), J Antimicrob Chemother, 72(7), 2089-92

DOI: 10.1093/jac/dkx085

Prosthetic joint infection: prevention update

Ierano C, Stewardson AJ, Peel T

(2017), In: Peel T (ed), Prosthetic Joint Infections, Springer, Chapter 5, 193-246

DOI: 10.1007/978-3-319-65250-4_5

Medication use and fall-related hospital admissions from long-term care facilities: a hospital-based case-control study

Ryan-Atwood TE, Hutchinson-Kern M, Ilomâki J, Dooley MJ, Poole SG, Kirkpatrick CM, Manias E, Mitra B, Bell JS

(2017), Drugs Aging, 34(8), 625-33

DOI: 10.1007/s40266-017-0472-8

Reducing medication errors in hospital discharge summaries: a randomised controlled trial

Tong EY, Roman CP, Mitra B, Yip GS, Gibbs H, Newnham HH, Smit V, Galbraith K, Dooley MJ

(2017), Med J Aust, 206(1), 36-9

DOI: 10.5694/mja16.00628

Report of the ISHLT Working Group on primary lung graft dysfunction Part IV: Prevention and treatment: A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation

Van Raemdonck D, Hartwig MG, Hertz MI, Davis RD, Cypel M, Hayes D Jr, Ivulich S, Kukreja J, Lease ED, Loor G, Mercier O, Paoletti L, Parmar J, Rampolla R, Wille K, Walia R, Keshavjee S

(2017), J Heart Lung Transplant, 36(10), 1121-36

DOI: 10.1016/j.healun.2017.07.013

Ritonavir and cobicistat

Duncan A

(2017), In: Grayson ML, Cosgrove SE, Crowe S, Hope W, McCarthy JS, Mills J, Mouton JW, Paterson DL (eds), Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, 7th edition, CRC Press, Chapter 248, 4180-213

Improving patient care today: more timely care and expanded roles of pharmacists

Tong EY, Dooley MJ

(2017), J Pharm Pract Res, 47(3), 173-5

DOI: 10.1002/jppr.1357

Why pharmacists need advanced practice specialist residences: the UK-Australia story

Dooley MJ, Coombes I, Michaels K, Duggan C, Bates I

(2017), J Pharm Pract Res, 47(3), 221-2

DOI: 10.1002/jppr.1364

Vismodegib

Coutsouvelis J

(2017), Aust Pharmacist, September, 54-7

Progressing advanced practice: the action so far, and the action ahead

Coombes I, Michaels K, Dooley MJ

(2017), J Pharm Pract Res, 47(6), 477-82

DOI: 10.1002/jppr.1370

A global declaration on appropriate use of antimicrobial agents across the surgical pathway

Global Alliance for Infections in Surgery Working Group

(2017), Surg Infect, 18(8), 846-53

DOI: 10.1089/sur.2017.219

Pharmacist-led therapeutic drug monitoring: implementation of a successful credentialing model

Cairns KA, O'Brien DJW, Corallo CE, Guidone DM, Dooley MJ

(2017), J Pharm Pract Res, 47(6), 477-82

DOI: 10.1002/jppr.1378

Β-Lactams dosing in overweight critically ill patients: are we driving in the dark?

Aubron C, Corallo C

(2017), Crit Care Med, 45(5), 923-5

DOI: 10.1097/CCM.0000000000002388

Timely initiation of chemotherapy: a systematic literature review of six priority cancers - results and recommendations for clinical practice

Alexander M, Blum R, Burbury K, Coutsouvelis J, Dooley M, Fazil O, Griffiths T, Ismail H, Joshi S, Love N, Opat S, Parente P, Porter N, Ross E, Siderov J, Thomas P, White S, Kirsa S, Rischin D

(2017), Intern Med J, 47(1), 16-34

DOI: 10.1111/imj.13190

The importance of risk communication and documentation for patients with cutaneous adverse drug reactions

Adler NR, Graudins LV, Aung AK

(2017), Br J Dermatol, 177(5), 1461

DOI: 10.1111/bjd.15737

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

van den Bent MJ, Baumert B, Erridge SC, Vogelbaum MA, Nowak AK, Sanson M, Brandes AA, Clement PM, Baurain JF, Mason WP, Wheeler H, Chinot OL, Gill S, Griffin M, Brachman DG, Taal W, Rudá R, Weller M, McBain C, Reijneveld J, Enting RH, Weber DC, Lesimple T, Clenton S, Gijtenbeek A, Pascoe S, Herrlinger U, Hau P, Dhermain F, van Heuvel I, Stupp R, Aldape K, Jenkins RB, Dubbink HJ, Dinjens WNM, Wesseling P, Nuyens S, Golfinopoulos V, Gorlia T, Wick W, Kros JM

(2017), Lancet, 390(10103), 1645-53

DOI: 10.1016/S0140-6736(17)31442-3

Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases

Parakh S, Park JJ, Mendis S, Rai R, Xu W, Lo S, Drummond M, Rowe C, Wong A, McArthur G, Haydon A, Andrews MC, Cebon J, Guminski A, Kefford RF, Long GV, Menzies AM, Klein O, Carlino MS

(2017), Br J Cancer, 116(12), 1558-63

DOI: 10.1038/bjc.2017.142

Tumour mutation status and sites of metastasis in patients with cutaneous melanoma

Adler NR, Wolfe R, Kelly JW, Haydon A, McArthur GA, McLean CA, Mar VJ

(2017), Br J Cancer, 117(7), 1026-35

DOI: 10.1038/bjc.2017.254

Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma

Long GV, Hauschild A, Santinami M, Atkinson V, Mandalá M, Chiarion-Sileni V, Larkin J, Nyakas M, Dutriaux C, Haydon A, Robert C, Mortier L, Schachter J, Schadendorf D, Lesimple T, Plummer R, Ji R, Zhang P, Mookerjee B, Legos J, Kefford R, Dummer R, Kirkwood JM

(2017), N Engl J Med, 377(19), 1813-23

DOI: 10.1056/NEJMoa1708539

Diffusion-tensor imaging findings and cognitive function following hospitalized mixed-mechanism mild traumatic brain injury: a systematic review and meta-analysis

Oehr L, Anderson J

(2017), Arch Phys Med Rehabil, 98(11), 2308-19

DOI: 10.1016/j.apmr.2017.03.019

387 388 389 390 391